A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
167/130, 167/202
A61K 31/70 (2006.01) A61K 39/12 (2006.01) C07K 14/07 (2006.01) C07K 14/52 (2006.01) C07K 14/525 (2006.01) C07K 14/57 (2006.01) C12N 15/62 (2006.01) C12N 15/85 (2006.01) C12N 15/863 (2006.01) A61K 38/00 (2006.01) A61K 39/00 (2006.01)
Patent
CA 1339346
A recombinant vaccine comprises a vaccine vector which incorporates a first nucleotide sequence capable of being expressed as all or a part of an antigenic polypeptide, together with a second nucleotide sequence capable of being expressed as all or a part of a lymphokine effective in enhancing the immune response to the antigenic polypeptide. The vaccine vectors include poxvirus, herpes virus or adenovirus, and the lymphokine may be an interleukin or gamma-interferon. The vaccine vector may express an antigenic polypeptide which is foreign to the host vector.
543498
Andrew Marion Elizabeth
Boyle David Bernard
Coupar Barbara Elizabeth Howieson
Ramshaw Ian Allister
Commonwealth Scientific And Industrial Research Organisation
Fetherstonhaugh & Co.
The Australian National University
LandOfFree
Recombinant chimeric vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Recombinant chimeric vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant chimeric vaccine will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1173680